Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease

Lorenz Kocheise^*, Ignazio Piseddu, Joscha Vonderlin, Eric T. Tjwa, Gustav Buescher, Lucy Meunier, Pia Goeggelmann, Francesca Fianchi, Jerome Dumortier, Mar Riveiro Barciela, Tom J. G. Gevers, Benedetta Terziroli Beretta-Piccoli, Maria-Carlota Londono, Sona Frankova, Thomas Roesner, Vincent Joerg, Constantin Schmidt, Fabian Glaser, Jan P. Sutter, Thorben W. FruendtAnsgar W. Lohse, Samuel Huber, Johann von Felden, Marcial Sebode, Kornelius Schulze

^*Corresponding author for this work

Research output: Contribution to journal › Erratum / corrigendum / retractions › Academic

1 Article

1 results

2024
PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease
Kocheise, L., Piseddu, I., Vonderlin, J., Tjwa, E. T., Buescher, G., Meunier, L., Goeggelmann, P., Fianchi, F., Dumortier, J., Riveiro Barciela, M., Gevers, T. J. G., Terziroli Beretta-Piccoli, B., Londono, M.-C., Frankova, S., Roesner, T., Joerg, V., Schmidt, C., Glaser, F., Sutter, J. P. & Fruendt, T. W. & 5 others, Lohse, A. W., Huber, S., von Felden, J., Sebode, M. & Schulze, K., 10 Jan 2024, In: Frontiers in Immunology. 14, 9 p., 1326078.
Research output: Contribution to journal › Article › Academic › peer-review

Open Access

Corrigendum: PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease

Research output

Search results

PD-1/PD-L1 immune checkpoint therapy demonstrates favorable safety profile in patients with autoimmune and cholestatic liver disease